Takeda and Insilico strike AI-led drug discovery deal worth up to $600m

Why It Matters

This Biotech development strengthens the region's biomanufacturing and life-sciences base. For Japan, it is a signal worth tracking: it shapes who supplies, who scales, and who sets the standard over the next five years.